Clinical Pharmacokinetics of Ketoconazole
暂无分享,去创建一个
[1] R. J. Hogg,et al. Candida peritonitis in children on continuous ambulatory peritoneal dialysis. , 1982, The International journal of pediatric nephrology.
[2] S. Sherlock,et al. Hepatic reactions associated with ketoconazole in the United Kingdom. , 1987, British medical journal.
[3] G. Valainis,et al. Ketoconazole Levels in Peritoneal Fluid , 1985 .
[4] T. Bates,et al. PHARMACOKINETICS OF KETOCONAZOLE-ANTIPYRINE INTERACTION , 1985, The Lancet.
[5] D. Warnock,et al. KETOCONAZOLE AND FUNGAL CAPD PERITONITIS , 1983, The Lancet.
[6] R. Hay. Ketoconazole: a reappraisal. , 1985, British medical journal.
[7] E. Johnson,et al. Influence of formulation on ketoconazole pharmacokinetics in man: comparison of standard tablet versus capsule containing citric acid. , 1986, The Journal of antimicrobial chemotherapy.
[8] J. V. D. van der Meer,et al. The influence of gastric acidity on the bio-availability of ketoconazole. , 1980, The Journal of antimicrobial chemotherapy.
[9] G. Sarosi,et al. Liquid chromatographic assay of ketoconazole , 1981, Antimicrobial Agents and Chemotherapy.
[10] H. Prentice,et al. KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS , 1982, The Lancet.
[11] E. Johnson,et al. Influence of food on the pharmacokinetics of ketoconazole , 1984, Antimicrobial Agents and Chemotherapy.
[12] G. Bodey,et al. Pharmacokinetics of ketoconazole in patients with neoplastic diseases , 1982, Antimicrobial Agents and Chemotherapy.
[13] D. Warnock,et al. High performance liquid chromatographic determination of ketoconazole in human serum. , 1986, The Journal of antimicrobial chemotherapy.
[14] T. Slama. Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. , 1983, The American journal of medicine.
[15] B. Wasilauskas,et al. Successful ketoconazole treatment of protothecosis with ketoconazole-associated hepatotoxicity. , 1983, Archives of internal medicine.
[16] E. Johnson,et al. Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. , 1983, The Journal of antimicrobial chemotherapy.
[17] A. Hume,et al. Ketoconazole (Nizoral, Janssen Pharmaceutica, Inc.) , 1983 .
[18] M. Gumbleton,et al. The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity. , 1985, Transplantation.
[19] D. White,et al. Cyclosporine and ketoconazole. , 1984, Transplantation.
[20] K. Alton. Determination of the antifungal agent, ketoconazole, in human plasma by high-performance liquid chromatography. , 1980, Journal of chromatography.
[21] W. S. Head,et al. Intraocular penetration of systemically administered antifungal agents. , 1985, Current eye research.
[22] E. Van Der Schueren,et al. Endocrine effects of high-dose ketoconazole therapy in advanced prostatic cancer. , 1985, Acta endocrinologica.
[23] E. Archimbaud,et al. Serum levels of ketoconazole in bone marrow transplanted patients. , 1983, Nouvelle revue francaise d'hematologie.
[24] Y. Clayton,et al. The treatment of patients with chronic mucocutaneous candidosis and Candida onychomycosis with ketoconazole , 1982, Clincal and Experimental Dermatology.
[25] E. Estey,et al. Infection prophylaxis in acute leukemia , 1984 .
[26] F. Port,et al. Ketoconazole Pharmacokinetics in Continuous Ambulatory Peritoneal Dialysis , 1984 .
[27] D. Engelhard,et al. Interaction of ketoconazole with rifampin and isoniazid. , 1984, The New England journal of medicine.
[28] M. James,et al. Determination of ketoconazole in the plasma, liver, lung and adrenal of the rat by high-performance liquid chromatography. , 1986, Journal of chromatography.
[29] K. Giacomini,et al. Measurement of ketoconazole, a new antifungal agent, by high-performance liquid chromatography. , 1982, Journal of Chromatography A.
[30] R. Hay. Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. , 1983, The American journal of medicine.
[31] C. Kirkpatrick,et al. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. , 1983, The American journal of medicine.
[32] D. Wheatley,et al. KETOCONAZOLE, CYCLOSPORIN, AND THE KIDNEY , 1982, The Lancet.
[33] J. Najarian,et al. KETOCONAZOLE, CYCLOSPORIN METABOLISM, AND RENAL TRANSPLANTATION , 1982, The Lancet.
[34] L. H. Schmidt. Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin , 1985, Antimicrobial Agents and Chemotherapy.
[35] M. Rinaldi,et al. Treatment of vaginal candidiasis with ketoconazole. , 1983, American journal of obstetrics and gynecology.
[36] D. Catovsky,et al. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. , 1984, The Journal of hospital infection.
[37] Jeanne Hawkins Tyle. Ketoconazole; Mechanism of Action, Spectrum of Activity, Pharmacokinetics, Drug Interactions, Adverse Reactions and Therapeutic Use , 1984 .
[38] P. Janssen,et al. Hepatic reactions during ketoconazole treatment. , 1983, The American journal of medicine.
[39] H. Mann,et al. Effect of pH on disintegration and dissolution of ketoconazole tablets. , 1983, American journal of hospital pharmacy.
[40] K. Olsen,et al. Pharmacology of ketoconazole suspension in infants and children , 1983, Antimicrobial Agents and Chemotherapy.
[41] J. G. Simpson,et al. Oral Ketoconazole: An Effective and Safe Treatment for Dermatophytosis , 1981 .
[42] W. Donovan,et al. Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens. , 1982, The American review of respiratory disease.
[43] D. Shepp,et al. Comparative Trial of Ketoconazole and Nystatin for Prevention of Fungal Infection in Neutropenic Patients Treated in a Protective Environment , 1985 .
[44] N. Badcock. Micro-determination of ketoconazole in plasma or serum by high-performance liquid chromatography. , 1984, Journal of chromatography.
[45] W. Amery,et al. EFFECTS OF HIGH DOSE KETOCONAZOLE THERAPY ON THE MAIN PLASMA TESTICULAR AND ADRENAL STEROIDS IN PREVIOUSLY UNTREATED PROSTATIC CANCER PATIENTS , 1986, Clinical endocrinology.
[46] H. Degreef,et al. Topical Ketoconazole in Dermatology: A Pharmacological and Clinical Review , 1984, Mykosen.
[47] J. Trachtenberg. Ketoconazole therapy in advanced prostatic cancer. , 1984, The Journal of urology.
[48] C. Kirkpatrick,et al. Treatment of fungal infections in the bones and joints with ketoconazole. , 1983, The Journal of infectious diseases.
[49] Y. Ishibashi. Oral ketoconazole therapy for keratomycosis. , 1983, American journal of ophthalmology.
[50] J. V. D. van der Meer,et al. CSF concentrations of ketoconazole. , 1980, The Journal of antimicrobial chemotherapy.
[51] R. J. Johnson,et al. Ketoconazole kinetics in chronic peritoneal dialysis , 1985, Clinical pharmacology and therapeutics.
[52] L. Martínez,et al. Topical ketoconazole for fungal keratitis. , 1985, American journal of ophthalmology.
[53] T. Blaschke,et al. Disposition of ketoconazole, an oral antifungal, in humans , 1982, Antimicrobial Agents and Chemotherapy.
[54] Magnasco Aj,et al. Interaction of ketoconazole and ethanol. , 1986 .
[55] D. Warnock,et al. Pharmacokinetics of ketoconazole in normal subjects. , 1981, The Journal of antimicrobial chemotherapy.
[56] M. Zemaitis,et al. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat. , 1986, Drug metabolism and disposition: the biological fate of chemicals.
[57] B. Duquesnoy,et al. Ketoconazole for treatment of Candida arthritis. , 1984, The Journal of rheumatology.
[58] Á. Restrepo,et al. Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience. , 1983, The American journal of medicine.
[59] H. Prentice,et al. The pharmacokinetics of ketoconazole in severely immunocompromised patients. , 1982, The Journal of antimicrobial chemotherapy.
[60] E. Gluckman,et al. NEPHROTOXICITY OF CYCLOSPORIN A IN BONE-MARROW TRANSPLANTATION , 1981, The Lancet.
[61] B. Dupont,et al. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. , 1983, The American journal of medicine.
[62] J. Graybill,et al. Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid , 1981, Antimicrobial Agents and Chemotherapy.
[63] M. Brown,et al. Effect of ketoconazole on hepatic oxidative drug metabolism , 1985, Clinical pharmacology and therapeutics.
[64] C. Kauffman,et al. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients. , 1984, Archives of internal medicine.
[65] J. Perfect,et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. , 1983, Annals of internal medicine.
[66] M. Schäfer-Korting,et al. Ketoconazole concentrations in human skin blister fluid and plasma. , 1984, International journal of clinical pharmacology, therapy, and toxicology.
[67] D. Warnock,et al. Clinical Pharmacokinetics of Systemic Antifungal Drugs , 1983, Clinical pharmacokinetics.
[68] E. Estey,et al. Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. , 1984, Archives of internal medicine.
[69] R. Fazio,et al. Ketoconazole treatment of Candida esophagitis--a prospective study of 12 cases. , 1983, The American journal of gastroenterology.
[70] J. Trachtenberg,et al. KETOCONAZOLE THERAPY FOR ADVANCED PROSTATE CANCER , 1984, The Lancet.
[71] P. Hykin,et al. Pulmonary Mycobacterium tuberculosis in acquired immune deficiency syndrome. , 1985, British medical journal.
[72] G. M. Shah,et al. Ketoconazole treatment of fungal infection in acute renal failure. , 1983, Clinical and experimental dialysis and apheresis.
[73] J. V. van Cutsem,et al. Treatment of vaginal candidosis with oral ketoconazole. , 1983, European journal of obstetrics, gynecology, and reproductive biology.
[74] T. Daneshmend,et al. Systemic absorption of ketoconazole from vaginal pessaries. , 1984, British journal of clinical pharmacology.
[75] C. Hörig,et al. Quantitative Bestimmung von Ketoconazl in den Haaren oral behandelter Ratten und Meerschweinchen , 1980 .
[76] B. J. Brooks,et al. Apparent ketoconazole failure in candidal cholecystitis. , 1982, Archives of internal medicine.
[77] A. Tortorano,et al. Pharmacokinetics of ketoconazole and treatment evaluation in candidal infections. , 1984, Archives of disease in childhood.
[78] R. Mäntylä,et al. Impairing effect of food on ketoconazole absorption , 1982, Antimicrobial Agents and Chemotherapy.
[79] W. Meuldermans,et al. Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsomes. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.
[80] D. Stevens,et al. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. , 1979, Postgraduate medical journal.
[81] H. Dieperink,et al. KETOCONAZOLE AND CYCLOSPORIN , 1982, The Lancet.
[82] F. Malecaze,et al. Etude expérimentale de la diffusion intra-oculaire du kétoconazole chez le lapin , 1985 .
[83] K. Speeg,et al. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[84] J. Mason,et al. Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[85] T. Mcelwain,et al. CYCLOSPORIN INTERACTION WITH KETOCONAZOLE AND MELPHALAN , 1982, The Lancet.
[86] K. Akl,et al. Ketoconazole treatment of Candida peritonitis during continuous peritoneal dialysis. , 1984, Pediatric infectious disease.
[87] W. Jusko,et al. Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion , 1986, Clinical pharmacology and therapeutics.
[88] W. Donovan,et al. Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients. , 1980, Reviews of infectious diseases.
[89] A. Thomson,et al. Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity. , 1984, Biochemical pharmacology.
[90] T. Blaschke,et al. Ketoconazole inhibits cyclosporine metabolism in vivo in mice. , 1986, The Journal of pharmacology and experimental therapeutics.
[91] J. V. van Cutsem,et al. Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. , 1979, European journal of obstetrics, gynecology, and reproductive biology.
[92] J. Jorgensen,et al. Simplified bioassay method for measurement of flucytosine or ketoconazole , 1985 .
[93] J. Galgiani,et al. High-dose ketoconazole therapy and adrenal and testicular function in humans. , 1984, Archives of internal medicine.
[94] J. Perfect,et al. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. , 1985, The Journal of antimicrobial chemotherapy.
[95] H. B. Levine. Ketoconazole in the management of fungal disease. , 1982 .
[96] J. Graybill,et al. High-dose ketoconazole for treatment of fungal infections of the central nervous system. , 1983, Annals of internal medicine.
[97] D. Feldman,et al. Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells. , 1983, The Journal of clinical investigation.
[98] C. Niemegeers,et al. Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole. , 1981, Archives internationales de pharmacodynamie et de therapie.
[99] J. Bennett,et al. Quantitation of ketoconazole in biological fluids using high-performance liquid chromatography. , 1983, Journal of pharmaceutical sciences.
[100] H. Jones,et al. Orally administered ketoconazole: route of delivery to the human stratum corneum , 1983, Antimicrobial Agents and Chemotherapy.
[101] Don E. Franckef. American Society of Hospital Pharmacists. , 1945, American journal of hospital pharmacy.
[102] B. Dupont,et al. Ketoconazole: spectre, pharmacocinétique, tolérance et activité thérapeutique dans les mycoses profondes , 1984 .
[103] G. Sarosi,et al. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. , 2020, Annals of internal medicine.
[104] J. Heykants,et al. Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers , 1986, Antimicrobial Agents and Chemotherapy.
[105] K. Ishak,et al. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. , 1984, Gastroenterology.
[106] J. Galgiani,et al. Ketoconazole therapy for fungal urinary tract infections. , 1983, The Journal of urology.
[107] Edgar B. Smith,et al. Ketoconazole: An Orally Effective Antifungal Agent Mechanism of Action, Pharmacology, Clinical Efficacy and Adverse Effects , 1984, Pharmacotherapy.